Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer
Aleksandra Adamska, Alice Domenichini, Emily Capone, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 21

Showing 21 citing articles:

Targeting multidrug resistance-associated protein 1 (MRP1)-expressing cancers: Beyond pharmacological inhibition
Kimberley M. Hanssen, Michelle Haber, Jamie I. Fletcher
Drug Resistance Updates (2021) Vol. 59, pp. 100795-100795
Closed Access | Times Cited: 71
Synergistic Anticancer Activity of Plumbagin and Xanthohumol Combination on Pancreatic Cancer Models
Ranjith Palanisamy, Nimnaka Indrajith Kahingalage, David Archibald, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2340-2340
Open Access | Times Cited: 8
Differences between KC and KPC pancreatic ductal adenocarcinoma mice models, in terms of their modeling biology and their clinical relevance
Abakundana Nsenga Ariston Gabriel, Qinlian Jiao, Yvette Umwali, et al.
Pancreatology (2019) Vol. 20, Iss. 1, pp. 79-88
Open Access | Times Cited: 47
Role of multidrug resistance-associated proteins in cancer therapeutics: past, present, and future perspectives
Ahmed Elfadadny, Hussein M. El‐Husseiny, Amira Abugomaa, et al.
Environmental Science and Pollution Research (2021) Vol. 28, Iss. 36, pp. 49447-49466
Closed Access | Times Cited: 37
The association of ABC proteins with multidrug resistance in cancer
Ana Elisa Zulliani Stroppa Marques, Bruna Estelita Ruginsk, Larissa de Oliveira Prado, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2024), pp. 119878-119878
Closed Access | Times Cited: 5
Fluorescence-based methods for studying activity and drug-drug interactions of hepatic solute carrier and ATP binding cassette proteins involved in ADME-Tox
Csilla Özvegy‐Laczka, Orsolya Ungvári, Éva Bakos
Biochemical Pharmacology (2023) Vol. 209, pp. 115448-115448
Open Access | Times Cited: 9
Matrix stiffness triggers chemoresistance through elevated autophagy in pancreatic ductal adenocarcinoma
Haopeng Pan, Shajun Zhu, Tiancheng Gong, et al.
Biomaterials Science (2023) Vol. 11, Iss. 22, pp. 7358-7372
Closed Access | Times Cited: 9
Pancreatic Adenocarcinoma: Unconventional Approaches for an Unconventional Disease
Christopher M. Gromisch, Motaz Qadan, Mariana Albuquerque Machado, et al.
Cancer Research (2020) Vol. 80, Iss. 16, pp. 3179-3192
Open Access | Times Cited: 24
Multi-Omics Data Integration Analysis of an Immune-Related Gene Signature in LGG Patients With Epilepsy
Quan Cheng, Weiwei Duan, Shiqing He, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 23
Targeting the Endocannabinoidome in Pancreatic Cancer
Valerio Falasca, Marco Falasca
Biomolecules (2022) Vol. 12, Iss. 2, pp. 320-320
Open Access | Times Cited: 14
Reversal of ABCB1-related multidrug resistance by ERK5-IN-1
Fang Wang, Delan Li, Zongheng Zheng, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 23
The implications of ABCC3 in cancer drug resistance: can we use it as a therapeutic target?
Adriana Ramírez-Cosmes, Edilburga Reyes-Jiménez, Cecilia Zertuche-Martínez, et al.
American Journal of Cancer Research (2021) Vol. 11, Iss. 9, pp. 4127-4140
Closed Access | Times Cited: 17
Inhibition of the Lysophosphatidylinositol Transporter ABCC1 Reduces Prostate Cancer Cell Growth and Sensitizes to Chemotherapy
Aikaterini Emmanouilidi, Ilaria Casari, Begum Gokcen Akkaya, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2022-2022
Open Access | Times Cited: 17
In silico identification of the prognostic biomarkers and therapeutic targets associated with cancer stem cell characteristics of glioma
Wen Lvu, Fei Xu, Cheng Chen, et al.
Bioscience Reports (2020) Vol. 40, Iss. 8
Open Access | Times Cited: 16
The Role of TRIP6, ABCC3 and CPS1 Expression in Resistance of Ovarian Cancer to Taxanes
Karolína Šeborová, Alžběta Spálenková, Kamila Koucká, et al.
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 73-73
Open Access | Times Cited: 14
A2B Adenosine Receptor Enhances Chemoresistance of Glioblastoma Stem-Like Cells under Hypoxia: New Insights into MRP3 Transporter Function
José Dellis Rocha, Daniel Uribe, Javiera Delgado, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9022-9022
Open Access | Times Cited: 4
Clinicopathological and Prognostic Significance of ABCC3 in Human Glioma
Dandong Fang, Wei Huang, Gang Cheng, et al.
Journal of Oncology (2021) Vol. 2021, pp. 1-8
Open Access | Times Cited: 5
Nicotinic Acetylcholine Receptors, Cannabinoid Receptors, and Their Interplay in Drug Addiction
Ana Sofía Vallés, Francisco J. Barrantes
(2024), pp. 289-305
Closed Access
3D-printed surgical wound dressing for prolonged 5-fluorouracil delivery from pluronic blending composites
Tz‐Feng Lin, Yi‐Jen Huang, Yi‐Jui Liu, et al.
Materials Today Communications (2022) Vol. 33, pp. 104284-104284
Closed Access | Times Cited: 2
TRANSPORTERS AS THERAPEUTIC TARGETS IN HUMAN DISEASES
Robert S. Jones, Eugene C. Chen
(2022), pp. 497-514
Closed Access | Times Cited: 1
HOXC10 promotes carboplatin resistance of ovarian cancer by regulating ABCC3.
Yuanyuan Li, Lei Han, Rihan Hai, et al.
PubMed (2022) Vol. 12, Iss. 10, pp. 4602-4621
Closed Access | Times Cited: 1
Page 1

Scroll to top